Olmesartan Medoxomil reports

Abdominal Discomfort while using Olmesartan Medoxomil

FDA FAERS contains adverse-event reports in which Olmesartan Medoxomil and abdominal discomfort appear together. This does not establish that Olmesartan Medoxomil caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Abdominal Pain Upper while using Olmesartan Medoxomil

FDA FAERS contains adverse-event reports in which Olmesartan Medoxomil and abdominal pain upper appear together. This does not establish that Olmesartan Medoxomil caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Abdominal Pain while using Olmesartan Medoxomil

FDA FAERS contains adverse-event reports in which Olmesartan Medoxomil and abdominal pain appear together. This does not establish that Olmesartan Medoxomil caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Acid reflux while using Olmesartan Medoxomil

FDA FAERS contains adverse-event reports in which Olmesartan Medoxomil and acid reflux appear together. This does not establish that Olmesartan Medoxomil caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Alopecia while using Olmesartan Medoxomil

FDA FAERS contains adverse-event reports in which Olmesartan Medoxomil and alopecia appear together. This does not establish that Olmesartan Medoxomil caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Anxiety while using Olmesartan Medoxomil

FDA FAERS contains adverse-event reports in which Olmesartan Medoxomil and anxiety appear together. This does not establish that Olmesartan Medoxomil caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Back Pain while using Olmesartan Medoxomil

FDA FAERS contains adverse-event reports in which Olmesartan Medoxomil and back pain appear together. This does not establish that Olmesartan Medoxomil caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Chest Discomfort while using Olmesartan Medoxomil

FDA FAERS contains adverse-event reports in which Olmesartan Medoxomil and chest discomfort appear together. This does not establish that Olmesartan Medoxomil caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Constipation while using Olmesartan Medoxomil

FDA FAERS contains adverse-event reports in which Olmesartan Medoxomil and constipation appear together. This does not establish that Olmesartan Medoxomil caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Cough while using Olmesartan Medoxomil

FDA FAERS contains adverse-event reports in which Olmesartan Medoxomil and cough appear together. This does not establish that Olmesartan Medoxomil caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Decreased Appetite while using Olmesartan Medoxomil

FDA FAERS contains adverse-event reports in which Olmesartan Medoxomil and decreased appetite appear together. This does not establish that Olmesartan Medoxomil caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Dehydration while using Olmesartan Medoxomil

FDA FAERS contains adverse-event reports in which Olmesartan Medoxomil and dehydration appear together. This does not establish that Olmesartan Medoxomil caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Diarrhea while using Olmesartan Medoxomil

FDA FAERS contains adverse-event reports in which Olmesartan Medoxomil and diarrhea appear together. This does not establish that Olmesartan Medoxomil caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Dizziness while using Olmesartan Medoxomil

FDA FAERS contains adverse-event reports in which Olmesartan Medoxomil and dizziness appear together. This does not establish that Olmesartan Medoxomil caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Dyspepsia while using Olmesartan Medoxomil

FDA FAERS contains adverse-event reports in which Olmesartan Medoxomil and dyspepsia appear together. This does not establish that Olmesartan Medoxomil caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Excessive sweating while using Olmesartan Medoxomil

FDA FAERS contains adverse-event reports in which Olmesartan Medoxomil and excessive sweating appear together. This does not establish that Olmesartan Medoxomil caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Fatigue while using Olmesartan Medoxomil

FDA FAERS contains adverse-event reports in which Olmesartan Medoxomil and fatigue appear together. This does not establish that Olmesartan Medoxomil caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Feeling Abnormal while using Olmesartan Medoxomil

FDA FAERS contains adverse-event reports in which Olmesartan Medoxomil and feeling abnormal appear together. This does not establish that Olmesartan Medoxomil caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Flushing while using Olmesartan Medoxomil

FDA FAERS contains adverse-event reports in which Olmesartan Medoxomil and flushing appear together. This does not establish that Olmesartan Medoxomil caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Headache while using Olmesartan Medoxomil

FDA FAERS contains adverse-event reports in which Olmesartan Medoxomil and headache appear together. This does not establish that Olmesartan Medoxomil caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Hives while using Olmesartan Medoxomil

FDA FAERS contains adverse-event reports in which Olmesartan Medoxomil and hives appear together. This does not establish that Olmesartan Medoxomil caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Hypotension while using Olmesartan Medoxomil

FDA FAERS contains adverse-event reports in which Olmesartan Medoxomil and hypotension appear together. This does not establish that Olmesartan Medoxomil caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Insomnia while using Olmesartan Medoxomil

FDA FAERS contains adverse-event reports in which Olmesartan Medoxomil and insomnia appear together. This does not establish that Olmesartan Medoxomil caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Itching while using Olmesartan Medoxomil

FDA FAERS contains adverse-event reports in which Olmesartan Medoxomil and itching appear together. This does not establish that Olmesartan Medoxomil caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Malaise while using Olmesartan Medoxomil

FDA FAERS contains adverse-event reports in which Olmesartan Medoxomil and malaise appear together. This does not establish that Olmesartan Medoxomil caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Muscle Spasms while using Olmesartan Medoxomil

FDA FAERS contains adverse-event reports in which Olmesartan Medoxomil and muscle spasms appear together. This does not establish that Olmesartan Medoxomil caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Muscular Weakness while using Olmesartan Medoxomil

FDA FAERS contains adverse-event reports in which Olmesartan Medoxomil and muscular weakness appear together. This does not establish that Olmesartan Medoxomil caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Myalgia while using Olmesartan Medoxomil

FDA FAERS contains adverse-event reports in which Olmesartan Medoxomil and myalgia appear together. This does not establish that Olmesartan Medoxomil caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Nausea while using Olmesartan Medoxomil

FDA FAERS contains adverse-event reports in which Olmesartan Medoxomil and nausea appear together. This does not establish that Olmesartan Medoxomil caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Pain while using Olmesartan Medoxomil

FDA FAERS contains adverse-event reports in which Olmesartan Medoxomil and pain appear together. This does not establish that Olmesartan Medoxomil caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Palpitations while using Olmesartan Medoxomil

FDA FAERS contains adverse-event reports in which Olmesartan Medoxomil and palpitations appear together. This does not establish that Olmesartan Medoxomil caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Peripheral swelling while using Olmesartan Medoxomil

FDA FAERS contains adverse-event reports in which Olmesartan Medoxomil and peripheral swelling appear together. This does not establish that Olmesartan Medoxomil caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Rash while using Olmesartan Medoxomil

FDA FAERS contains adverse-event reports in which Olmesartan Medoxomil and rash appear together. This does not establish that Olmesartan Medoxomil caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Shortness of breath while using Olmesartan Medoxomil

FDA FAERS contains adverse-event reports in which Olmesartan Medoxomil and shortness of breath appear together. This does not establish that Olmesartan Medoxomil caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Skin redness while using Olmesartan Medoxomil

FDA FAERS contains adverse-event reports in which Olmesartan Medoxomil and skin redness appear together. This does not establish that Olmesartan Medoxomil caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Sleepiness while using Olmesartan Medoxomil

FDA FAERS contains adverse-event reports in which Olmesartan Medoxomil and sleepiness appear together. This does not establish that Olmesartan Medoxomil caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Tingling or pins and needles while using Olmesartan Medoxomil

FDA FAERS contains adverse-event reports in which Olmesartan Medoxomil and tingling or pins and needles appear together. This does not establish that Olmesartan Medoxomil caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Tremor while using Olmesartan Medoxomil

FDA FAERS contains adverse-event reports in which Olmesartan Medoxomil and tremor appear together. This does not establish that Olmesartan Medoxomil caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Vision Blurred while using Olmesartan Medoxomil

FDA FAERS contains adverse-event reports in which Olmesartan Medoxomil and vision blurred appear together. This does not establish that Olmesartan Medoxomil caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Vomiting while using Olmesartan Medoxomil

FDA FAERS contains adverse-event reports in which Olmesartan Medoxomil and vomiting appear together. This does not establish that Olmesartan Medoxomil caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Weakness while using Olmesartan Medoxomil

FDA FAERS contains adverse-event reports in which Olmesartan Medoxomil and weakness appear together. This does not establish that Olmesartan Medoxomil caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Weight Decreased while using Olmesartan Medoxomil

FDA FAERS contains adverse-event reports in which Olmesartan Medoxomil and weight decreased appear together. This does not establish that Olmesartan Medoxomil caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Weight Increased while using Olmesartan Medoxomil

FDA FAERS contains adverse-event reports in which Olmesartan Medoxomil and weight increased appear together. This does not establish that Olmesartan Medoxomil caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →